Penumbra, Inc. (PEN) short interest & options flow
NYSEPenumbra reports Q3 results on November 2 against a backdrop that has shifted fundamentally since its last print. A agreed acquisition by Boston Scientific means the earnings call is now as much about deal confidence as underlying business momentum. The most telling signal heading into the print is not short interest or options skew but the BSX stock itself. BSX fell…
PEN cost to borrow surges to 0.96%, up 194% over one week, as availability remains abundant at 935% of short interest.
- Market cap
- $12.71B
- Next earnings
- 19 Feb 2027
Key data as of 5 Nov 2026
Latest signals on PEN
- Cost to Borrow
PEN cost to borrow surges to 0.96%, up 194% over one week, as availability remains abundant at 935% of short interest.
2 Cost to Borrow updates in 30 days
PEN news and analysis
RSSNo long-form analysis yet for PEN. Pulse alerts and the live data picture are available on ORTEX.
Open PEN on ORTEX →Want the live picture for PEN?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PEN — free to start on ORTEX.
Sign up for free →Open PEN on ORTEX